Skip to main content
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1975 Feb;51(1):51–53. doi: 10.1136/sti.51.1.51

Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.

B A Wood, A M Monro
PMCID: PMC1045111  PMID: 1092424

Abstract

Serum concentrations of tinidazole and metronidazole have been measured in healthy female volunteers who received a single dose of 2 g. of each drug in a cross-over study. Bioassays against T. vaginalis showed that metronidazole achieved higher peak concentrations (mean 81 mug./ml.) than did tinidazole (mean 67 mug./ml.), while assays for unchanged drug showed higher peak concentrations of tinidazole )mean 51 mug./ml;) than of metronidazole (mean 40 mug./ml9). This discrepancy is probably due to the presence in the serum of active metabolites of metronidazole. The longer half-life of tinidazole led to significantly higher serum concentrations (by bioassay and chemical assay) of tinidazole than of metronidazole from 6 hrs onwards.

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Csonka G. W. Trichomonal vaginitis treated with one dose of metronidazole. Br J Vener Dis. 1971 Dec;47(6):456–458. doi: 10.1136/sti.47.6.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Forsgren A., Wallin J. Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation. Br J Vener Dis. 1974 Apr;50(2):146–147. doi: 10.1136/sti.50.2.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Howes H. L., Jr, Lynch J. E., Kivlin J. L. Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa. Antimicrob Agents Chemother (Bethesda) 1969;9:261–266. [PubMed] [Google Scholar]
  4. Rösemann G. W., Vaughan J. Treatment of trichomoniasis in the female with a single dose of tinidazole. S Afr Med J. 1973 Jul 21;47(28):1222–1224. [PubMed] [Google Scholar]
  5. Stambaugh J. E., Feo L. G., Manthei R. W. The isolation and identification of the urinary oxidative metabolites of metronidazole in man. J Pharmacol Exp Ther. 1968 Jun;161(2):373–381. [PubMed] [Google Scholar]
  6. Taylor J. A., Jr, Migliardi J. R., Von Wittenau M. S. Tinidazole and metronidazole pharmocokinetics in man and mouse. Antimicrob Agents Chemother (Bethesda) 1969;9:267–270. [PubMed] [Google Scholar]
  7. Wallin J., Forsgren A. Tinidazole--a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose. Br J Vener Dis. 1974 Apr;50(2):148–150. doi: 10.1136/sti.50.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Welling P. G., Monro A. M. The pharmacokinetics of metronidazole and tinidazole in man. Arzneimittelforschung. 1972 Dec;22(12):2128–2132. [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES